Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China.
Li M, Cao Y, Huang H, Qin G, Chu M, Zou M, Zhuang X.
Li M, et al.
BMC Public Health. 2023 Nov 13;23(1):2228. doi: 10.1186/s12889-023-17052-1.
BMC Public Health. 2023.
PMID: 37953277
Free PMC article.
METHODS: A decision-analytic Markov model was used to obtain the costs and effectiveness of four regimens: Arm A, efavirenz (EFV)-based regimen; Arm B, DTG-based regimen; Arm C, elvitegravir/cobicistat/tenofovir alafenamide/emtricitabine (EVG/c/FTC/TAF) regimen; Arm D, abacavir/l …
METHODS: A decision-analytic Markov model was used to obtain the costs and effectiveness of four regimens: Arm A, efavirenz (EFV)-based regi …